Illinois Municipal Retirement Fund Sells 7,804 Shares of Axon Enterprise, Inc $AXON

Illinois Municipal Retirement Fund reduced its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 66.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,854 shares of the biotechnology company’s stock after selling 7,804 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Axon Enterprise were worth $3,191,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. TCI Wealth Advisors Inc. bought a new stake in shares of Axon Enterprise during the 2nd quarter valued at $214,000. Duncker Streett & Co. Inc. boosted its stake in Axon Enterprise by 3.2% in the 2nd quarter. Duncker Streett & Co. Inc. now owns 14,501 shares of the biotechnology company’s stock worth $12,006,000 after purchasing an additional 448 shares during the period. EFG Asset Management North America Corp. grew its holdings in Axon Enterprise by 17.8% during the 2nd quarter. EFG Asset Management North America Corp. now owns 12,701 shares of the biotechnology company’s stock valued at $10,511,000 after buying an additional 1,918 shares in the last quarter. New York Life Investment Management LLC increased its position in shares of Axon Enterprise by 3.2% during the second quarter. New York Life Investment Management LLC now owns 11,044 shares of the biotechnology company’s stock valued at $9,144,000 after buying an additional 341 shares during the period. Finally, Sivia Capital Partners LLC bought a new stake in shares of Axon Enterprise during the second quarter valued at about $284,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In other news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $591.04, for a total value of $5,910,400.00. Following the sale, the chief executive officer directly owned 3,023,982 shares in the company, valued at approximately $1,787,294,321.28. This trade represents a 0.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Brittany Bagley sold 5,000 shares of the firm’s stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the sale, the chief financial officer directly owned 93,592 shares of the company’s stock, valued at $66,813,456.96. The trade was a 5.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 52,041 shares of company stock valued at $36,794,077 over the last ninety days. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $569.51 on Thursday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a fifty-two week low of $469.24 and a fifty-two week high of $885.91. The firm has a market cap of $44.94 billion, a PE ratio of 140.62, a price-to-earnings-growth ratio of 29.49 and a beta of 1.45. The business has a 50 day moving average price of $709.82 and a 200-day moving average price of $735.72.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, November 4th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $710.64 million during the quarter, compared to the consensus estimate of $704.83 million. During the same period last year, the business earned $1.45 EPS. Axon Enterprise’s revenue was up 30.6% on a year-over-year basis. Axon Enterprise has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. Equities research analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Analyst Upgrades and Downgrades

AXON has been the topic of several research analyst reports. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. The Goldman Sachs Group reduced their target price on Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a research report on Wednesday, November 5th. UBS Group decreased their target price on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Needham & Company LLC reaffirmed a “buy” rating and issued a $870.00 price target on shares of Axon Enterprise in a report on Wednesday, September 24th. Finally, Cowen reissued a “buy” rating on shares of Axon Enterprise in a report on Wednesday, November 5th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $810.71.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.